iBio Reports Preliminary Unaudited Fiscal Year 2022 Financial Results and Provides Corporate Update

September 27, 2022

https://www.globenewswire.com/news-release/2022/09/27/2523812/0/en/iBio-Reports-Preliminary-Unaudited-Fiscal-Year-2022-Financial-Results-and-Provides-Corporate-Update.html

BRYAN, Texas and SAN DIEGO, Sept. 27, 2022 (GLOBE NEWSWIRE) — iBio, Inc. (NYSEA:IBIO) (“iBio” or the “Company”), a developer of next-generation biopharmaceuticals and pioneer of the sustainable FastPharming® Manufacturing System, today announces preliminary unaudited financial results for the fiscal year ended June 30, 2022, and provides a corporate update.

Read more at globenewswire.com

Related news for (IBIO)

NASDAQ and NYSE quotes and data are delayed 15 minutes unless indicated otherwise. Market data and exchange information are provided for informational purposes only and is not intended for trading purposes. Neither 24/7 Market News Editors, 247 Market News, or data and content providers shall be liable for any errors or omissions, delays, misquotes or other market information relayed in any press materials. You should Use Realtime data to conduct due diligence before investing or trading, and trading in any stock is risky you could lose all your money.